Pharmaceutical CDMO, Global Market Size Forecast, Top 20 Players Rank and Market Share | |
Pharmaceutical CDMO Market Summary According to the new market research report "Global Pharmaceutical CDMO Market Report 2023-2029", published by QYResearch, the global Pharmaceutical CDMO market size is projected to grow from USD 88 billion in 2023 to USD 164240 million by 2029, at a CAGR of 10.9% during the forecast period. According to QYResearch Top Players Research Center, the global key manufacturers of Pharmaceutical CDMO include Thermo Fisher Scientific, Lonza, WuXi Department, Jubilant, Catalent, Samsung Bio, Pfizer CentreOne, Delpharm, Kai Laiying, Fareva Group, etc. In 2022, the global top 10 players had a share approximately 65% in terms of revenue. For more information, please contact the following e-mail address: Email: global@qyresearch.com Website: https://www.qyresearch.com | |
Target State: All States Target City : All Cities Last Update : 12 April 2024 11:55 AM Number of Views: 75 | Item Owner : Laura Contact Email: (None) Contact Phone: (None) |
Friendly reminder: Click here to read some tips. |